Other equities research analysts also recently issued reports about the company. Deutsche Bank AG upped their price objective on BTG plc from GBX 740 ($9.16) to GBX 840 ($10.40) and gave the company a buy rating in a research report on Tuesday, July 12th. JPMorgan Chase & Co. reduced their price target on BTG plc from GBX 800 ($9.90) to GBX 790 ($9.78) and set a neutral rating on the stock in a report on Friday, July 15th. Jefferies Group reiterated a buy rating and issued a GBX 860 ($10.64) price target on shares of BTG plc in a report on Friday, July 15th. Royal Bank Of Canada increased their price target on BTG plc from GBX 820 ($10.15) to GBX 890 ($11.01) and gave the stock an outperform rating in a report on Wednesday, June 8th. Finally, Numis Securities Ltd reiterated a hold rating and issued a GBX 654 ($8.09) price target on shares of BTG plc in a report on Friday, June 24th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. BTG plc currently has an average rating of Buy and an average target price of GBX 799.57 ($9.90).
BTG plc (LON:BTG) opened at 701.00 on Thursday. The stock’s market cap is GBX 2.68 billion. The firm’s 50-day moving average price is GBX 633.03 and its 200-day moving average price is GBX 642.16. BTG plc has a 52 week low of GBX 504.00 and a 52 week high of GBX 739.50.
In related news, insider Soderstrom,Rolf sold 74,327 shares of the stock in a transaction that occurred on Thursday, July 21st. The stock was sold at an average price of GBX 676 ($8.37), for a total value of £502,450.52 ($621,844.70).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.